(Boursier.com) — Abivax announces the resumption of trading of its ordinary shares on Euronext in Paris from 4:20 p.m. The trading price of Abivax’s ordinary shares was suspended at the request of the Company on October 20 as part of its global offering, in order to allow the confirmation of allocations to investors and the start of trading of American Depositary Shares (ADS). of the Company on the Nasdaq Global Market. The price was set at $11.60 per ADS as part of the US offer and corresponds to a price of 10.9864 euros per ordinary share. The total gross amount is estimated at approximately $235.8 million, equivalent to approximately €223.3 million, before deduction of financial intermediary commissions and estimated fees to be paid by the Company.
©2023 Boursier.com